Mirum Pharmaceuticals Inc logo

Mirum Pharmaceuticals Inc share price today

(MIRM)

Mirum Pharmaceuticals Inc share price is $45.59 & ₹3,860.79

$45.59

-0.62

(-1.35%)

Market is closed - opens 8 PM, 04 Dec 2024

View live Mirum Pharmaceuticals Inc share price in Dollar and Rupees. Guide to invest in Mirum Pharmaceuticals Inc from India. Also see the sentimental analysis on Indian investors investing in Mirum Pharmaceuticals Inc. Get details on the Indian mutual funds that are investing in Mirum Pharmaceuticals Inc. Get Analyst recommendations and forecasts along with all the Mirum Pharmaceuticals Inc's financials.

Mirum Pharmaceuticals Inc share price movements

  • $45.19
    $46.73

    Day's Volatility :3.3%

  • $23.14
    $48.89

    52 Weeks Volatility :52.67%

Mirum Pharmaceuticals Inc Returns

PeriodMirum Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
10.55%
-6.2%
0.0%
6 Months
75.7%
1.7%
0.0%
1 Year
42.18%
11.6%
0.0%
3 Years
248.75%
12.9%
-18.1%

Mirum Pharmaceuticals Inc Key Statistics

in dollars & INR

Market Capitalization
$2.2B
Revenue TTM
$307.0M
EBITDA
$-72.9M
Earnings Per Share (EPS)
$-2.08
Profit Margin
-32.51%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-39.84%

How to invest in Mirum Pharmaceuticals Inc from India?

It is very easy for Indian residents to invest directly in Mirum Pharmaceuticals Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mirum Pharmaceuticals Inc stock in both rupees (INR) and dollars (USD). Search for Mirum Pharmaceuticals Inc or MIRM on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mirum Pharmaceuticals Inc or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mirum Pharmaceuticals Inc shares which would translate to 0.019 fractional shares of Mirum Pharmaceuticals Inc as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Mirum Pharmaceuticals Inc

567%

Period: Sep 4, 2024 to Dec 3, 2024. Change in 30 Days versus previous period

Search volume for Mirum Pharmaceuticals Inc on INDmoney from India has grown in the last 30 days as on Dec 4, 2024. 567% more investors are searching Mirum Pharmaceuticals Inc in the last 30 days versus the previous period.

Global Institutional Holdings in Mirum Pharmaceuticals Inc

  • HHG PLC

    9.33%

  • Eventide Asset Management, LLC

    7.18%

  • BlackRock Inc

    6.75%

  • Bvf Inc

    6.41%

  • Vanguard Group Inc

    5.20%

  • State Street Corp

    3.74%

Analyst Recommendation on Mirum Pharmaceuticals Inc

Buy

    94%Buy

    5%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Mirum Pharmaceuticals Inc(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
15
15
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Mirum Pharmaceuticals Inc

What analysts predicted

Upside of 37.19%

Current:

$45.59

Target:

$62.55

Insights on Mirum Pharmaceuticals Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 69.22M → 90.37M (in $), with an average increase of 12.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -33.14M → -14.23M (in $), with an average increase of 35.6% per quarter
  • Vs ALNY

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 47.6% return, outperforming this stock by 3.2%

Mirum Pharmaceuticals Inc Technicals Summary

Sell

Neutral

Buy

Mirum Pharmaceuticals Inc is currently in a neutral trading position according to technical analysis indicators.

Mirum Pharmaceuticals Inc Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mirum Pharmaceuticals Inc
14.24%
75.7%
42.18%
248.75%
432.37%
Regeneron Pharmaceuticals, Inc.
-8.02%
-24.21%
-7.13%
21.97%
104.79%
Biontech Se
7.55%
14.34%
18.7%
-58.12%
380.92%
Alnylam Pharmaceuticals, Inc.
-6.28%
66.39%
48.51%
42.94%
104.44%
Vertex Pharmaceuticals Incorporated
-1.5%
-3.58%
31.51%
127.12%
108.61%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mirum Pharmaceuticals Inc
NA
NA
NA
-1.46
-0.4
-0.09
NA
4.84
Regeneron Pharmaceuticals, Inc.
18.55
18.55
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.23
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mirum Pharmaceuticals Inc
Buy
$2.2B
432.37%
NA
-32.51%
Regeneron Pharmaceuticals, Inc.
Buy
$83.0B
104.79%
18.55
33.61%
Biontech Se
Buy
$28.9B
380.92%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
104.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$120.6B
108.61%
32.84
-4.51%

Mirum Pharmaceuticals Inc Dividend announcements

  • Mirum Pharmaceuticals Inc Earnings

    Mirum Pharmaceuticals Inc’s price-to-earnings ratio stands at None

    Read More

About Mirum Pharmaceuticals Inc

mirum pharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. its lead product candidate is maralixibat, an investigational oral drug that is in phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of alagille syndrome and biliary atresia disease. the company is also develops volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. mirum pharmaceuticals, inc. was founded in 2018 and is headquartered in foster city, california.
Organization
Mirum Pharmaceuticals Inc
Employees
311
CEO
Mr. Christopher Peetz
Industry
Health Technology

Important FAQs about investing in Mirum Pharmaceuticals Inc from India :

What is Mirum Pharmaceuticals Inc share price today?

Mirum Pharmaceuticals Inc (MIRM) share price today is $45.59.

Can Indians buy Mirum Pharmaceuticals Inc shares?

Yes, Indians can invest in the Mirum Pharmaceuticals Inc (MIRM) from India.

With INDmoney, you can buy Mirum Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mirum Pharmaceuticals Inc at zero transaction cost.

How can I buy Mirum Pharmaceuticals Inc shares from India?

It is very easy to buy Mirum Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mirum Pharmaceuticals Inc be purchased?

Yes, you can buy fractional shares of Mirum Pharmaceuticals Inc with INDmoney app.

What are the documents required to start investing in Mirum Pharmaceuticals Inc stocks?

To start investing in Mirum Pharmaceuticals Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mirum Pharmaceuticals Inc

Today’s highest price of Mirum Pharmaceuticals Inc (MIRM) is $46.73.

Today’s lowest price of Mirum Pharmaceuticals Inc (MIRM) is $45.19.

What is today's market capitalisation of Mirum Pharmaceuticals Inc

Today's market capitalisation of Mirum Pharmaceuticals Inc MIRM is 2.2B

What is the 52 Week High and Low Range of Mirum Pharmaceuticals Inc

  • 52 Week High

    $48.89

  • 52 Week Low

    $23.14

How much percentage Mirum Pharmaceuticals Inc is down from its 52 Week High?

Mirum Pharmaceuticals Inc (MIRM) share price is $45.59. It is down by 99% from its 52 Week High price of $48.89.

How much percentage Mirum Pharmaceuticals Inc is up from its 52 Week low?

Mirum Pharmaceuticals Inc (MIRM) share price is $45.59. It is up by 1% from its 52 Week Low price of $23.14.

What are the historical returns of Mirum Pharmaceuticals Inc?

  • 1 Month Returns

    14.24%

  • 3 Months Returns

    75.7%

  • 1 Year Returns

    42.18%

  • 5 Years Returns

    432.37%

Who is the Chief Executive Officer (CEO) of Mirum Pharmaceuticals Inc

Mr. Christopher Peetz is the current Chief Executive Officer (CEO) of Mirum Pharmaceuticals Inc.